Sphingosine 1-phosphate pathway is dysregulated in adenomyosis
Other
OA: closed
CC0
⤵ 3 in-corpus citations
AI-generated summary
This paper investigates the sphingosine 1-phosphate pathway and finds it to be dysregulated in adenomyosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
RESEARCH QUESTION: Is sphingosine 1-phosphate (S1P) pathway involved in the process of fibrosis in adenomyosis?
DESIGN: RNA was extracted from paraffin-embedded slices collected from the ectopic endometrium of patients with nodular adenomyosis (n = 27) and eutopic endometrium of healthy controls women (n = 29). Expression of genes involved in the metabolism and signalling of S1P, and actin-alpha-2 smooth muscle, encoded by ACTA2 gene, a gene involved in fibrogenesis, was evaluated by real-time polymerase chain reaction analysis.
RESULTS: In adenomyotic samples, the expression of sphingosine kinase 1 (SPHK1), the enzyme responsible for the synthesis of S1P, and of S1P phosphatase 2 (SGPP2), the enzyme responsible for the conversion of S1P back to sphingosine, was lower (P = 0.0006; P = 0.0015), whereas that of calcium and integrin-binding protein 1, responsible for membrane translocation of SPHK1, was higher (P = 0.0001) compared with healthy controls. In S1P signalling, a higher expression of S1P receptor S1P3 (P = 0.001), and a lower expression of S1P2 (P = 0.0019) mRNA levels, were found compared with healthy endometrium. In adenomyotic nodules, a higher expression of ACTA2 mRNA levels were observed (P = 0.0001), which correlated with S1P3 levels (P = 0.0138).
CONCLUSION: Present data show a profound dysregulation of the S1P signalling axis in adenomyosis. This study also highlights that the bioactive sphingolipid might be involved in the fibrotic tract of the disease, correlated with the expression of ACTA2, suggesting its role as novel potential biomarker of adenomyosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (8)
- Expression of Cannabinoid Receptors in Myometrium and its Correlation With Dysmenorrhea in Adenomyosis via openalex
- Pathogenesis of adenomyosis: an update on molecular mechanisms via openalex
- Sphingosine 1-phosphate receptors are dysregulated in endometriosis: possible implication in transforming growth factor β-induced fibrosis via openalex
- Transcriptome analysis of eutopic endometrium in adenomyosis after GnRH agonist treatment via openalex
- W6806883953 via openalex
- W2114570899 via openalex
- W3109586781 via openalex
- W2005467120 via openalex
Cited by (5)
- Adenomyosis: Current Status and Future Prospects of Drugs Inhibiting Epithelial-Mesenchymal Transition 2026
- Tailored management of abnormal uterine bleeding and pain in adenomyosis across the life course 2026
- Estrogen-Progesterone Sequential Exposure Induces the Fibrosis of Adenomyosis in Mice 2026
- Imaging and molecular features of adenomyosis after menopause 2024
- The Role of Platelets in the Pathogenesis and Pathophysiology of Adenomyosis 2023
Source provenance
- europepmc
- last seen: 2026-11-07T06:14:47.903349+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:35:10.661171+00:00
- unpaywall
- last seen: 2026-11-06T06:34:47.334260+00:00
License: CC0
· commercial use OK